Covered recipient · General Payments record
TIMOTHY J WIERZBICKI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$1,628.24
- Reported across 86 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.37 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.60 | 9 |
| BIOTRONIK NRO, Inc. | $29.49 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.69 | 1 |
| UCB, Inc. | $21.22 | 1 |
| Grifols USA, LLC | $19.40 | 1 |
| Lundbeck LLC | $17.34 | 1 |
| Neurocrine BioSciences, Inc. | $16.16 | 1 |
| Amgen Inc. | $14.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.40 | 01/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745876 | CMS |
| ABBVIE INC. | $16.53 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745879 | CMS |
| ABBVIE INC. | $11.25 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745883 | CMS |
| ABBVIE INC. | $12.77 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745886 | CMS |
| ABBVIE INC. | $17.99 | 04/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745890 | CMS |
| ABBVIE INC. | $20.33 | 05/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745895 | CMS |
| ABBVIE INC. | $16.08 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745898 | CMS |
| ABBVIE INC. | $30.99 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745903 | CMS |
| ABBVIE INC. | $32.26 | 11/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204745906 | CMS |
| Amgen Inc. | $14.47 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227072092 | CMS |
| BIOTRONIK NRO, Inc. | $29.49 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246330354 | CMS |
| Grifols USA, LLC | $19.40 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249554166 | CMS |
| Lundbeck LLC | $17.34 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251859607 | CMS |
| Neurocrine BioSciences, Inc. | $16.16 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243039761 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.69 | 10/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223871911 | CMS |
| UCB, Inc. | $21.22 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224362528 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.